Preservation solutions
AssigneeOrgan Preservation Solutions Limited
InventorsTerence Simon Corbitt, Malgosia Jarmolowicz, Clare Lankester, Jeremy Peter Alan Lodge, Oluseun Olarewaju, David John Potts
Life of this patent
Estimating the term…
Loading patent…
AssigneeOrgan Preservation Solutions Limited
InventorsTerence Simon Corbitt, Malgosia Jarmolowicz, Clare Lankester, Jeremy Peter Alan Lodge, Oluseun Olarewaju, David John Potts
Estimating the term…
There is described a preservation solution for the preservation of cells, tissues and/or organs, said solution comprising: (i) water for injection; (ii) at least one saccharide; (iii) at least one component with pH buffer properties; (iv) optionally at least one component with calcium transport blocking properties or an anti-calcium action activity; (v) salicylic acid, in free form or in salt form, or aspirin; and (vi) glutamic acid, in free form or in salt form, or glutamine; provided that acetamide is absent and/or if aspirin is present glutamine is absent and if glutamine is present aspirin is absent.
A preservation solution for the preservation of cells, tissues and/or organs, in the absence of a blood supply, said solution comprising:
4-6. (canceled)
(canceled)
11-14. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
33-34. (canceled)
36-40. (canceled)
42-56. (canceled)
58-67. (canceled)
A method for the preservation of cells for simple hypothermic storage, in particular living cells, tissues or organs whereby the cells, tissue or organs are brought into contact with a preservation solution comprising:
69-100. (canceled)
A preservation solution for the preservation of cells, tissues and/or organs, in the absence of a blood supply, said solution comprising:
(canceled)
A preservation solution for the preservation of cells, tissues and/or organs, in the absence of a blood supply, said solution comprising:
Dependencies are inferred from the claim text.